The AEMPS publishes the memorandum of ethics committees for drug research
Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) for the evaluation and management of observational studies with medicines’, whose objective is to facilitate CEIm the consistent, rigorous and homogeneous application of the requirements established in Royal Decree […]
The MD Anderson Cancer Center in Madrid inaugurates one of the largest Phase I Clinical Trials units in Europe
Source: www.immedicohospitalario.es The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center Madrid has inaugurated its Phase I Clinical Trials Unit, one of the largest units in Spain and Europe and which expects to serve, in a total of 725 square […]
Farmaindustria estimates the investment in 2020 of pharmaceutical companies in research at 39,000 million
Source: www.actasanitaria.com Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the most important assets for biomedical progress and the economy”, since it invested “39,000 million euros in research in 2020 and it directly employed some 830,000 people ”. This is […]
The medicine, health, social and economic value
Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as a whole For every euro invested in new medicines, the public health system saves between 2 and 7 euros in other health benefits ‘The value of medicine’, a space […]
The investment of the pharmaceutical industry in R&D grows in 2020 despite the pandemic
Via: www.consalud.es The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This is reflected in a new report carried out by the analysis firm CRO IQVIA collected by FierceBiotech, which shows that, in general, the activity of clinical trials recovered from […]
Spain, a country of reference in conducting clinical trials
Via: www.immedicohospitalario.es Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new treatments. This Thursday, May 20, the Clinical Trial Day is celebrated around the world. The pandemic has brought this concept closer to the general society, increasingly familiar with the […]
The pharmaceutical industry has almost 90 drugs under development against antimicrobial resistance
Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can range from 10 to 20.5 years The sector’s commitment to responding to this problem for global public health is total, although it requires incentive policies to make this market […]
“Europe has the challenge of regaining ground lost to the US and Asia in drug research” “
In just two decades, the European Union has gone from leading global biomedical R&D to being the origin of only 23% of new drugs, while 47% already come from the United States The new Pharmaceutical Strategy promoted by the European Commission may be an opportunity, if done well, to reinforce investment in innovation and production […]
Digitization in clinical research advances for the benefit of patients
The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends that healthcare and biomedical research go hand in hand in the management of patient data The objective is to offer all the guarantees of a lawful, responsible and ethical […]
Observational studies with drugs published in the Spanish Trial Registry
Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with drugs for human use, in force since January 2, provides for the Publication in the Spanish Registry of clinical studies (REec) of the information on observational studies with drugs […]
ES
EN